TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ACTU

Actuate Therapeutics, Inc.

Healthcare · Biotechnology

0.7316$ -9.4% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ACTU
Line item 2022 2023 2024 2025
– – – –
– +32.5% -14.0% -44.9%
– -14.5% +98.6% +88.2%
– +23.6% +0.7% -10.6%
– – – –
– +169.4% -57.1% +8.2%
– – – –
– – – +0.0%
– – – –
– – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?